Aravax to Present PVX108 Phase 1 Clinical Trial Results at AAAAI 2019 Annual Meeting

Ads

You May Also Like

Surface Oncology to Present at Goldman Sachs 39th Annual Global Healthcare Conference

CAMBRIDGE, Mass., June 08, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology ...

Myriad Acquires Sividon Diagnostics

SALT LAKE CITY, May 31, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a ...

ADMA Biologics to Present at Upcoming Investor Conferences

RAMSEY, N.J., Aug. 23, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or ...